Author:
Lebrecht Dirk,Walker Ulrich A.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference49 articles.
1. Buzdar, A. U., Marcus, C., Smith, T. L., & Blumenschein, G. R. (1985). Early and delayed clinical cardiotoxicity of doxorubicin. Cancer, 55, 2761–2765.
2. Steinherz, L. J., Steinherz, P. G., Tan, C. T., Heller, G., & Murphy, M. L. (1991). Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA, 266, 1672–1677.
3. Minow, R. A., Benjamin, R. S., & Gottlieb, J. A. (1975). Adriamycin (NSC-123127) cardiomyopathy – an overview with determination of risk factors. Cancer Chemotheraphy Reports, 6, 195–201.
4. Ferrans, V. J. (1978). Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treatment Reports, 62, 955–961.
5. Davies, K. J. A., & Doroshow, J. H. (1986). Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. Journal of Biological Chemistry, 261, 3060–3967.
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献